Robert M. Rzasa

851 total citations
16 papers, 499 citations indexed

About

Robert M. Rzasa is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert M. Rzasa has authored 16 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 6 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Robert M. Rzasa's work include Synthetic Organic Chemistry Methods (3 papers), Cancer therapeutics and mechanisms (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Robert M. Rzasa is often cited by papers focused on Synthetic Organic Chemistry Methods (3 papers), Cancer therapeutics and mechanisms (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Robert M. Rzasa collaborates with scholars based in United States, Austria and New Zealand. Robert M. Rzasa's co-authors include Daniel Romo, Hélène A. Shea, Kaapjoo Park, Jun O. Liu, James R. Falsey, Luo Sun, Joseph M. Langenhan, Mark H. Norman, Dawei Zhang and Robert D. Larsen and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Robert M. Rzasa

14 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert M. Rzasa United States	12	326	149	73	54	54	16	499
Liping H. Pettus United States	15	398 1.2×	217 1.5×	67 0.9×	42 0.8×	20 0.4×	24	573
Steven M. Sparks United States	16	690 2.1×	295 2.0×	126 1.7×	37 0.7×	61 1.1×	25	980
Nobuko Nishimura United States	14	224 0.7×	124 0.8×	23 0.3×	159 2.9×	22 0.4×	17	491
Hiroyuki Nakahira Japan	13	329 1.0×	150 1.0×	22 0.3×	11 0.2×	48 0.9×	25	500
Alessandro A. Boezio Canada	17	676 2.1×	334 2.2×	36 0.5×	43 0.8×	26 0.5×	26	853
Manomi A. Tennakoon United States	7	278 0.9×	137 0.9×	44 0.6×	18 0.3×	68 1.3×	9	328
Daniel B. Horne United States	9	427 1.3×	152 1.0×	29 0.4×	77 1.4×	38 0.7×	11	570
Paul C. Fritch United States	9	564 1.7×	349 2.3×	122 1.7×	8 0.1×	99 1.8×	12	692
Yasuhiro Yonetoku Japan	12	200 0.6×	200 1.3×	30 0.4×	31 0.6×	7 0.1×	20	491
Joel K. Kawakami United States	12	213 0.7×	140 0.9×	109 1.5×	14 0.3×	8 0.1×	16	438

Countries citing papers authored by Robert M. Rzasa

Since Specialization

Citations

This map shows the geographic impact of Robert M. Rzasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Rzasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Rzasa more than expected).

Fields of papers citing papers by Robert M. Rzasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Rzasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Rzasa. The network helps show where Robert M. Rzasa may publish in the future.

Co-authorship network of co-authors of Robert M. Rzasa

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Rzasa. A scholar is included among the top collaborators of Robert M. Rzasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Rzasa. Robert M. Rzasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rzasa, Robert M., Essa Hu, Ning Chen, et al.. (2012). Discovery of selective biaryl ethers as PDE10A inhibitors: Improvement in potency and mitigation of Pgp-mediated efflux. Bioorganic & Medicinal Chemistry Letters. 22(24). 7371–7375. 21 indexed citations

Bryan, Marian C., Kaustav Biswas, Robert M. Rzasa, et al.. (2011). Chromenones as potent bradykinin B1 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(1). 619–622. 9 indexed citations

Reichelt, Andreas, James R. Falsey, Robert M. Rzasa, et al.. (2010). Palladium-Catalyzed Chemoselective Monoarylation of Hydrazides for the Synthesis of [1,2,4]Triazolo[4,3-a]pyridines. Organic Letters. 12(4). 792–795. 68 indexed citations

Kaller, Matthew R., Wenge Zhong, Charles M. Henley, et al.. (2009). Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6591–6594. 8 indexed citations

Rzasa, Robert M., Matthew R. Kaller, Gang Liu, et al.. (2007). Structure–activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Bioorganic & Medicinal Chemistry. 15(20). 6574–6595. 30 indexed citations

Low, Woon‐Kai, Yongjun Dang, Tilman Schneider‐Poetsch, et al.. (2007). Isolation and Identification of Eukaryotic Initiation Factor 4A as a Molecular Target for the Marine Natural Product Pateamine A. Methods in enzymology on CD-ROM/Methods in enzymology. 431. 303–324. 27 indexed citations

Zhong, Wenge, Hu Liu, Matthew R. Kaller, et al.. (2007). Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(19). 5384–5389. 23 indexed citations

Norman, Mark H., Jiawang Zhu, Christopher Fotsch, et al.. (2007). Novel Vanilloid Receptor-1 Antagonists: 1. Conformationally Restricted Analogues oftrans-Cinnamides. Journal of Medicinal Chemistry. 50(15). 3497–3514. 35 indexed citations

Doherty, Elizabeth M., Christopher Fotsch, Anthony W. Bannon, et al.. (2007). Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate. Journal of Medicinal Chemistry. 50(15). 3515–3527. 68 indexed citations

10.

Romo, Daniel, Robert M. Rzasa, William D. Schmitz, et al.. (2000). Total Synthesis of Marine Natural Products Driven by Novel Structure, Potent Biological Activity, and/or Synthetic Methodology. PubMed. 103–148.

11.

Molander, Gary A. & Robert M. Rzasa. (2000). Hetero Diels−Alder Reactions Catalyzed by the Metallocenium Complex [Cp*₂Ce][BPh₄]. The Journal of Organic Chemistry. 65(4). 1215–1217. 19 indexed citations

12.

Rzasa, Robert M., Hélène A. Shea, & Daniel Romo. (1998). ChemInform Abstract: Total Synthesis of the Novel, Immunosuppressive Agent (‐)‐Pateamine A from Mycale sp. Employing a β‐Lactam‐Based Macrocyclization.. ChemInform. 29(24). 1 indexed citations

13.

Romo, Daniel, Robert M. Rzasa, Hélène A. Shea, et al.. (1998). Total Synthesis and Immunosuppressive Activity of (−)-Pateamine A and Related Compounds: Implementation of a β-Lactam-Based Macrocyclization. Journal of the American Chemical Society. 120(47). 12237–12254. 106 indexed citations

14.

Rzasa, Robert M., Hélène A. Shea, & Daniel Romo. (1998). Total Synthesis of the Novel, Immunosuppressive Agent (−)-Pateamine A from Mycale sp. Employing a β-Lactam-Based Macrocyclization. Journal of the American Chemical Society. 120(3). 591–592. 57 indexed citations

15.

Rzasa, Robert M., Daniel Romo, David Stirling, John W. Blunt, & Murray H. G. Munro. (1995). Structural and synthetic studies of the pateamines: Synthesis and absolute configuration of the hydroxydienoate fragment. Tetrahedron Letters. 36(30). 5307–5310. 14 indexed citations

16.

Rzasa, Robert M.. (1995). Structural and Synthetic Studies of the Pateamines: Synthesis and Absolute Configuration of the Hydroxydienoate Fragment. Tetrahedron Letters. 36(30). 5307–5310. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact